Oxaliplatin (L-OHP) in combination with leucovorin and bolus-continuous infusion 5fluorouracil (LV5FU2) in advanced colorectal cancer (ACC) pretreated with 5FU

被引：1
|
作者：
Beretta, GD
Cascinu, S
Zaniboni, A
Ratti, R
Giordani, P
Catalano, V
Martignoni, G
Barni, S
Frontini, L
Labianca, R
机构：
[1] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
[2] Univ Messina, Messina, Italy
[3] Casa Cura Poliambulanza, Brescia, Italy
[4] Casa Cura Igea, Milan, Italy
[5] Osped Muraglia, Pesaro, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)80689-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
256
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [31] Oxaliplatin (L-OHP) in combination with 5-fluorouracil (5-FU)/l-leucovorin (l-LV) on modified Roswell Park regimen as first-line treatment of advanced colorectal cancer (ACRC):: A phase I/II study.
    Miyata, Y
    Shirao, K
    Ohtsu, A
    Boku, N
    Tanigawara, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 295S - 295S
  • [32] A simplified bi-monthly regimen with leucovorin (LV) and 5-Fluorouracil (5FU) for metastatic colorectal cancer (MCRC)
    Tournigand, C
    de Gramont, A
    Louvet, C
    Andre, T
    Carola, E
    Gilles-Amar, V
    Maindrault-Goebel, F
    Lotz, JP
    Molitor, JL
    ANNALS OF ONCOLOGY, 1998, 9 : 40 - 40
  • [33] Combined radiotherapy, 5-Fluorouracil (5FU) continuous infusion and weekly Oxaliplatin in advanced rectal cancer: Phase I study
    Francois, Eric D.
    Ychou, Marc
    Ducreux, Michel
    Bertheault-Cvitkovic, Frederique
    Giovannini, Marc
    Conroy, Thierry
    Lemansk, Claire
    Thomas, Oliver
    Mari, Veronique
    ANNALS OF ONCOLOGY, 2004, 15 : 96 - 97
  • [34] Combination of leucovorin, 5-fluorouracil bolus and infusion, and cisplatin (LV5FU2-P regimen) in the treatment of advanced upper gastrointestinal carcinomas (AUGIC).
    Mitry, E
    Artru, P
    Taieb, J
    Boige, V
    Vaillant, JN
    Clavero-Fabri, MC
    Lesur, G
    Dupuy, P
    Ducreux, M
    Rougier, P
    ANNALS OF ONCOLOGY, 2000, 11 : 65 - 65
  • [35] Oxaliplatin (OXA), 5-fluorouracil (5-FU) and leucovorin (LV) in patients with advanced or metastatic gastric cancer (A/MGC).
    Cavanna, L
    Zaniboni, A
    Artioli, F
    Lazzaro, A
    Rizzi, A
    Mazzocchi, M
    Bernuzzi, P
    Bertè, R
    Bidin, L
    Palladino, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 330S - 330S
  • [36] Oxaliplatin (L-OHP) plus levo-folinic acid (I-FA) and 5-fluorouracil (5FU)-FOLFOX2 regimen in second-third-line chemotherapy (CT) of advanced colorectal cancer (ACC).
    Luppi, G
    Zanelli, F
    Lombardo, L
    Giannetta, L
    ANNALS OF ONCOLOGY, 2000, 11 : 48 - 48
  • [37] TREATMENT OF ADVANCED GASTRIC-CANCER WITH METHOTREXATE (MTX), 5-FLUOROURACIL (5FU), LEUCOVORIN (LV), CISPLATIN (DDP)
    BRUCKNER, HW
    SUNG, MW
    CHESSER, M
    WONG, H
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 203 - 203
  • [38] Phase II trial of 5-fluorouracil (5FU)/leucovorin (LV), irinotecan, and oxaliplatin (FOLFOXIRI) plus cetuximab in patients with metastatic colorectal cancer (mCRC).
    Sougklakos, I.
    Vardakis, N. K.
    Kampouraki, E.
    Kotortsi, I.
    Androulakis, N. E. M.
    Vamvakas, L.
    Kalbakis, K.
    Hatzidaki, D.
    Mavroudis, D.
    Georgoulias, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [39] Pharmacokinetics of 5-fluorouracil (5-FUra) in patients with metastatic colorectal cancer receiving 5-FUra bolus plus continuous infusion with high dose folinic acid (LV5FU2)
    Joulia, JM
    Pinguet, F
    Ychou, M
    Duffour, J
    Topart, D
    Grosse, PY
    Astre, C
    Bressolle, F
    ANTICANCER RESEARCH, 1997, 17 (4A) : 2727 - 2730
  • [40] A prospective randomized study of irinotecan (CPT-11), leucovorin (LV) and 5-fluorouracil (5FU) versus leucovorin and 5-fluorouracil in patients with advanced colorectal carcinoma
    Gennatas, C.
    Papaxoinis, G.
    Michalaki, V.
    Mouratidou, D.
    Andreadis, Ch.
    Tsavaris, N.
    Pafiti, A.
    JOURNAL OF CHEMOTHERAPY, 2006, 18 (05) : 538 - 544
12345